Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Squamous Cell Cancer of Head and Neck|Triple Negative Breast Cancer|Epithelial Ovarian Cancer|Malignant Melanoma|Advanced Solid Tumors
Interventions: BIOLOGICAL: Pembrolizumab
Sponsor: University Health Network, Toronto
Collaborators: Merck Sharp & Dohme LLC